{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:39:48Z","timestamp":1753893588538,"version":"3.41.2"},"reference-count":27,"publisher":"Sociedade Brasileira de Cardiologia","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,4]]},"DOI":"10.36660\/abc.20220277","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T11:56:33Z","timestamp":1680695793000},"source":"Crossref","is-referenced-by-count":0,"title":["Associa\u00e7\u00e3o entre o Antagonismo do Sistema Renina-Angiotensina-Aldosterona e a Mortalidade Relacionada \u00e0 COVID-19 em Pacientes com Hipertens\u00e3o Relacionada ao Sobrepeso\/Obesidade: um Estudo Retrospectivo de Coorte"],"prefix":"10.36660","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2581-8813","authenticated-orcid":false,"given":"Elham","family":"Shams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7106-7286","authenticated-orcid":false,"given":"Vijayvardhan","family":"Kamalumpundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linhai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeyinka","family":"Taiwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Shibli-Rahhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayotunde O.","family":"Dokun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3470-6234","authenticated-orcid":false,"given":"Marcelo L.G.","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"10","key":"key20230405075627_B1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/s41371-020-00459-3","article-title":"A Historical Perspective on ACE2 in the COVID-19 Era","volume":"35","author":"Bhalla","year":"2021","unstructured":"1. Bhalla V, Blish CA, South AM. A Historical Perspective on ACE2 in the COVID-19 Era. J Hum Hypertens. 2021;35(10):935-39. doi: 10.1038\/s41371-020-00459-3.","journal-title":"J Hum Hypertens"},{"issue":"10","key":"key20230405075627_B2","doi-asserted-by":"crossref","first-page":"e1008235","DOI":"10.1371\/journal.pcbi.1008235","article-title":"Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis","volume":"16","author":"Sadria","year":"2020","unstructured":"2. Sadria M, Layton AT. Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis. PLoS Comput Biol. 2020;16(10):e1008235. doi: 10.1371\/journal.pcbi.1008235.","journal-title":"PLoS Comput Biol"},{"key":"key20230405075627_B3","doi-asserted-by":"crossref","first-page":"110231","DOI":"10.1016\/j.mehy.2020.110231","article-title":"COVID-19 and the Renin-Angiotensin System (RAS): A Spark that Sets the Forest Alight?","volume":"144","author":"Wiese","year":"2020","unstructured":"3. Wiese OJ, Allwood BW, Zemlin AE. COVID-19 and the Renin-Angiotensin System (RAS): A Spark that Sets the Forest Alight? Med Hypotheses. 2020;144:110231. doi: 10.1016\/j.mehy.2020.110231.","journal-title":"Med Hypotheses"},{"issue":"3","key":"key20230405075627_B4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cmet.2021.01.016","article-title":"Diabetes, Obesity, Metabolism, and Sars-Cov-2 Infection: The End of the Beginning","volume":"33","author":"Drucker","year":"2021","unstructured":"4. Drucker DJ. Diabetes, Obesity, Metabolism, and Sars-Cov-2 Infection: The End of the Beginning. Cell Metab. 2021;33(3):479-98. doi: 10.1016\/j.cmet.2021.01.016.","journal-title":"Cell Metab"},{"issue":"10","key":"key20230405075627_B5","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/cvr\/cvaa097","article-title":"Hypertension, the Renin-Angiotensin System, and the Risk of Lower Respiratory Tract Infections and Lung Injury: Implications for COVID-19","volume":"116","author":"Kreutz","year":"2020","unstructured":"5. Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, et al. Hypertension, the Renin-Angiotensin System, and the Risk of Lower Respiratory Tract Infections and Lung Injury: Implications for COVID-19. Cardiovasc Res. 2020;116(10):1688-99. doi: 10.1093\/cvr\/cvaa097.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"key20230405075627_B6","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients with Hypertension Hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","unstructured":"6. Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients with Hypertension Hospitalized with COVID-19. Circ Res. 2020;126(12):1671-81. doi: 10.1161\/CIRCRESAHA.120.317134.","journal-title":"Circ Res"},{"issue":"7","key":"key20230405075627_B7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/oby.22831","article-title":"High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation","volume":"28","author":"Simonnet","year":"2020","unstructured":"7. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity (Silver Spring). 2020;28(7):1195-9. doi: 10.1002\/oby.22831.","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"key20230405075627_B8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41440-020-0485-2","article-title":"COVID-19 Patients with Hypertension Have More Severe Disease: A Multicenter Retrospective Observational Study","volume":"43","author":"Huang","year":"2020","unstructured":"8. Huang S, Wang J, Liu F, Liu J, Cao G, Yang C, et al. COVID-19 Patients with Hypertension Have More Severe Disease: A Multicenter Retrospective Observational Study. Hypertens Res. 2020;43(8):824-31. doi: 10.1038\/s41440-020-0485-2.","journal-title":"Hypertens Res"},{"issue":"1","key":"key20230405075627_B9","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06378-z","article-title":"High Risk Groups for Severe COVID-19 in a Whole of Population Cohort in Australia","volume":"21","author":"Liu","year":"2021","unstructured":"9. Liu B, Spokes P, He W, Kaldor J. High Risk Groups for Severe COVID-19 in a Whole of Population Cohort in Australia. BMC Infect Dis. 2021;21(1):685. doi: 10.1186\/s12879-021-06378-z.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"key20230405075627_B10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41587-020-00796-1","article-title":"Hypertension Delays Viral Clearance and Exacerbates Airway Hyperinflammation in Patients with COVID-19","volume":"39","author":"Trump","year":"2021","unstructured":"10. Trump S, Lukassen S, Anker MS, Chua RL, Liebig J, Th\u00fcrmann L, et al. Hypertension Delays Viral Clearance and Exacerbates Airway Hyperinflammation in Patients with COVID-19. Nat Biotechnol. 2021;39(6):705-16. doi: 10.1038\/s41587-020-00796-1.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"key20230405075627_B11","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13313","article-title":"COVID-19 Infection, Progression, and Vaccination: Focus on Obesity and Related Metabolic Disturbances","volume":"22","author":"Westheim","year":"2021","unstructured":"11. Westheim AJF, Bitorina AV, Theys J, Shiri-Sverdlov R. COVID-19 Infection, Progression, and Vaccination: Focus on Obesity and Related Metabolic Disturbances. Obes Rev. 2021;22(10):e13313. doi: 10.1111\/obr.13313.","journal-title":"Obes Rev"},{"issue":"1","key":"key20230405075627_B12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jmv.26220","article-title":"Why Obesity, Hypertension, Diabetes, and Ethnicities are Common Risk Factors for COVID-19 and H1N1 Influenza Infections","volume":"93","author":"Miyazawa","year":"2021","unstructured":"12. Miyazawa D. Why Obesity, Hypertension, Diabetes, and Ethnicities are Common Risk Factors for COVID-19 and H1N1 Influenza Infections. J Med Virol. 2021;93(1):127-8. doi: 10.1002\/jmv.26220.","journal-title":"J Med Virol"},{"issue":"2","key":"key20230405075627_B13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/dom.14228","article-title":"Relationship between Obesity and Severe COVID-19 Outcomes in Patients with Type 2 Diabetes: Results from the CORONADO Study","volume":"23","author":"Smati","year":"2021","unstructured":"13. Smati S, Tramunt B, Wargny M, Caussy C, Gaborit B, Vatier C, et al. Relationship between Obesity and Severe COVID-19 Outcomes in Patients with Type 2 Diabetes: Results from the CORONADO Study. Diabetes Obes Metab. 2021;23(2):391-403. doi: 10.1111\/dom.14228.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"key20230405075627_B14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients with COVID-19 and Hypertension: A Single-Center Retrospective Study","volume":"76","author":"Yang","year":"2020","unstructured":"14. Yang G, Tan Z, Zhou L, Yang M, Peng L, Liu J, et al. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients with COVID-19 and Hypertension: A Single-Center Retrospective Study. Hypertension. 2020;76(1):51-8. doi: 10.1161\/HYPERTENSIONAHA.120.15143.","journal-title":"Hypertension"},{"key":"key20230405075627_B15","volume-title":"IDSA Guidelines on the Treatment and Management of Patients with COVID-19","author":"Infectious Diseases Society of America","year":"2020","unstructured":"15. Infectious Diseases Society of America. IDSA Guidelines on the Treatment and Management of Patients with COVID-19. Arlington: IDSA; 2020."},{"issue":"3","key":"key20230405075627_B16","doi-asserted-by":"crossref","first-page":"e213071","DOI":"10.1001\/jamanetworkopen.2021.3071","article-title":"Comparison of Time to Clinical Improvement with vs without Remdesivir Treatment in Hospitalized Patients with COVID-19","volume":"4","author":"Garibaldi","year":"2021","unstructured":"16. Garibaldi BT, Wang K, Robinson ML, Zeger SL, Bandeen-Roche K, Wang MC, et al. Comparison of Time to Clinical Improvement with vs without Remdesivir Treatment in Hospitalized Patients with COVID-19. JAMA Netw Open. 2021;4(3):e213071. doi: 10.1001\/jamanetworkopen.2021.3071.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"key20230405075627_B17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"Horby","year":"2021","unstructured":"17. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693-704. doi: 10.1056\/NEJMoa2021436.","journal-title":"N Engl J Med"},{"key":"key20230405075627_B18","first-page":"100660","article-title":"The Influence of ACE Inhibitors and ARBs on Hospital Length of Stay and Survival in People with COVID-19","volume":"31","author":"Braude","year":"2020","unstructured":"18. Braude P, Carter B, Short R, Vilches-Moraga A, Verduri A, Pearce L, et al. The Influence of ACE Inhibitors and ARBs on Hospital Length of Stay and Survival in People with COVID-19. Int J Cardiol Heart Vasc. 2020;31:100660. doi: 10.1016\/j.ijcha.2020.100660.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"9","key":"key20230405075627_B19","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/nu12092748","article-title":"Very Low-Carbohydrate Ketogenic Diet for the Treatment of Severe Obesity and Associated Non-Alcoholic Fatty Liver Disease: The Role of Sex Differences","volume":"12","author":"D\u2019Abbondanza","year":"2020","unstructured":"19. D\u2019Abbondanza M, Ministrini S, Pucci G, Nulli Migliola E, Martorelli EE, Gandolfo V, et al. Very Low-Carbohydrate Ketogenic Diet for the Treatment of Severe Obesity and Associated Non-Alcoholic Fatty Liver Disease: The Role of Sex Differences. Nutrients. 2020;12(9):2748. doi: 10.3390\/nu12092748.","journal-title":"Nutrients"},{"key":"key20230405075627_B20","doi-asserted-by":"crossref","first-page":"100283","DOI":"10.1016\/j.obmed.2020.100283","article-title":"Association of High Level Gene Expression of ACE2 in Adipose Tissue with Mortality of COVID-19 Infection in Obese Patients","volume":"19","author":"Al-Benna","year":"2020","unstructured":"20. Al-Benna S. Association of High Level Gene Expression of ACE2 in Adipose Tissue with Mortality of COVID-19 Infection in Obese Patients. Obes Med. 2020;19:100283. doi: 10.1016\/j.obmed.2020.100283.","journal-title":"Obes Med"},{"issue":"4","key":"key20230405075627_B21","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are Patients with Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","unstructured":"21. Fang L, Karakiulakis G, Roth M. Are Patients with Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. doi: 10.1016\/S2213-2600(20)30116-8.","journal-title":"Lancet Respir Med"},{"issue":"13","key":"key20230405075627_B22","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.3390\/ijms22136703","article-title":"Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms","volume":"22","author":"Yalcin","year":"2021","unstructured":"22. Yalcin HC, Sukumaran V, Al-Ruweidi MKAA, Shurbaji S. Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms. Int J Mol Sci. 2021;22(13):6703. doi: 10.3390\/ijms22136703.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"key20230405075627_B23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-Converting Enzyme 2 (ACE2) as a SARS-CoV-2 Receptor: Molecular Mechanisms and Potential Therapeutic Target","volume":"46","author":"Zhang","year":"2020","unstructured":"23. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-Converting Enzyme 2 (ACE2) as a SARS-CoV-2 Receptor: Molecular Mechanisms and Potential Therapeutic Target. Intensive Care Med. 2020;46(4):586-90. doi: 10.1007\/s00134-020-05985-9.","journal-title":"Intensive Care Med"},{"key":"key20230405075627_B24","doi-asserted-by":"crossref","first-page":"110748","DOI":"10.1016\/j.biopha.2020.110748","article-title":"Male Predisposition to Severe COVID-19: Review of Evidence and Potential Therapeutic Prospects","volume":"131","author":"Acheampong","year":"2020","unstructured":"24. Acheampong DO, Barffour IK, Boye A, Aninagyei E, Ocansey S, Morna MT. Male Predisposition to Severe COVID-19: Review of Evidence and Potential Therapeutic Prospects. Biomed Pharmacother. 2020;131:110748. doi: 10.1016\/j.biopha.2020.110748.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"key20230405075627_B25","doi-asserted-by":"crossref","first-page":"e2114741","DOI":"10.1001\/jamanetworkopen.2021.14741","article-title":"Association of Remdesivir Treatment with Survival and Length of Hospital Stay Among US Veterans Hospitalized with COVID-19","volume":"4","author":"Ohl","year":"2021","unstructured":"25. Ohl ME, Miller DR, Lund BC, Kobayashi T, Richardson Miell K, Beck BF, et al. Association of Remdesivir Treatment with Survival and Length of Hospital Stay Among US Veterans Hospitalized with COVID-19. JAMA Netw Open. 2021;4(7):e2114741. doi: 10.1001\/jamanetworkopen.2021.14741.","journal-title":"JAMA Netw Open"},{"key":"key20230405075627_B26","doi-asserted-by":"crossref","DOI":"10.18332\/tid\/119324","article-title":"COVID-19 and Smoking: A Systematic Review of the Evidence","volume":"18","author":"Vardavas","year":"2020","unstructured":"26. Vardavas CI, Nikitara K. COVID-19 and Smoking: A Systematic Review of the Evidence. Tob Induc Dis. 2020;18:20. doi: 10.18332\/tid\/119324.","journal-title":"Tob Induc Dis"},{"issue":"5","key":"key20230405075627_B27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamainternmed.2020.8360","article-title":"Association of Smoking and Cumulative Pack-Year Exposure with COVID-19 Outcomes in the Cleveland Clinic COVID-19 Registry","volume":"181","author":"Lowe","year":"2021","unstructured":"27. Lowe KE, Zein J, Hatipoglu U, Attaway A. Association of Smoking and Cumulative Pack-Year Exposure with COVID-19 Outcomes in the Cleveland Clinic COVID-19 Registry. JAMA Intern Med. 2021;181(5):709-11. doi: 10.1001\/jamainternmed.2020.8360.","journal-title":"JAMA Intern Med"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/associacao-entre-o-antagonismo-do-sistema-renina-angiotensina-aldosterona-e-a-mortalidade-relacionada-a-covid-19-em-pacientes-com-hipertensao-relacionada-ao-sobrepeso-obesidade-um-estudo-retrospectiv\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:12:24Z","timestamp":1747401144000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/associacao-entre-o-antagonismo-do-sistema-renina-angiotensina-aldosterona-e-a-mortalidade-relacionada-a-covid-19-em-pacientes-com-hipertensao-relacionada-ao-sobrepeso-obesidade-um-estudo-retrospectiv\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,4]]}},"alternative-id":["10.36660\/abc.20220277"],"URL":"https:\/\/doi.org\/10.36660\/abc.20220277","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2023,3]]},"article-number":"e20220277"}}